Literature DB >> 20811316

SLC19A1 pharmacogenomics summary.

Sook Wah Yee1, Li Gong, Ilaria Badagnani, Kathleen M Giacomini, Teri E Klein, Russ B Altman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20811316      PMCID： PMC2956130          DOI： 10.1097/FPC.0b013e32833eca92

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  59 in total

1.  Genetic polymorphism (G80A) of reduced folate carrier gene in ethnic populations.

Authors:  P L Rady; S Szucs; R K Matalon; J Grady; S D Hudnall; L H Kellner; H Nitowsky
Journal:  Mol Genet Metab       Date:  2001-07       Impact factor: 4.797

2.  The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter.

Authors:  Johnathan R Whetstine; Robin M Flatley; Larry H Matherly
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

3.  Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia.

Authors:  Caroline Laverdière; Sonia Chiasson; Irina Costea; Albert Moghrabi; Maja Krajinovic
Journal:  Blood       Date:  2002-11-15       Impact factor: 22.113

4.  Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells.

Authors:  Rongbao Zhao; Feng Gao; I David Goldman
Journal:  Am J Physiol Cell Physiol       Date:  2002-06       Impact factor: 4.249

5.  Polymorphisms in genes involved in folate metabolism as risk factors for NTDs.

Authors:  P De Marco; M G Calevo; A Moroni; L Arata; E Merello; A Cama; R H Finnell; L Andreussi; V Capra
Journal:  Eur J Pediatr Surg       Date:  2001-12       Impact factor: 2.191

6.  Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake.

Authors:  S Drori; G Jansen; R Mauritz; G J Peters; Y G Assaraf
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

7.  Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida.

Authors:  Gary M Shaw; Edward J Lammer; Huiping Zhu; Mei Wang Baker; Eric Neri; Richard H Finnell
Journal:  Am J Med Genet       Date:  2002-02-15

8.  The human reduced folate carrier gene is regulated by the AP2 and sp1 transcription factor families and a functional 61-base pair polymorphism.

Authors:  Johnathan R Whetstine; Teah L Witt; Larry H Matherly
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

9.  Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines.

Authors:  Lilah Rothem; Ilan Ifergan; Yotam Kaufman; David G Priest; Gerrit Jansen; Yehuda G Assaraf
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

10.  Role of the E45K-reduced folate carrier gene mutation in methotrexate resistance in human leukemia cells.

Authors:  A J Gifford; M Haber; T L Witt; J R Whetstine; J W Taub; L H Matherly; M D Norris
Journal:  Leukemia       Date:  2002-12       Impact factor: 11.528
View more
  10 in total

1.  Gene polymorphisms in the folate metabolic pathway and risk of pediatric acute lymphoblastic leukemia: a case-control study in a Chinese population.

Authors:  Hui Lv; Shao-Yan Hu; Zhi-Zuo Du; Zong Zhai; Lan Cao; Yi-Na Sun; Jun Lu; Jie Li; Hai-Long He; Yi-Huan Chai; Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan.

Authors:  Laith N Al-Eitan; Doaa M Rababa'h; Nancy M Hakooz; Mansour A Alghamdi; Rana B Dajani
Journal:  J Pers Med       Date:  2020-01-06

3.  Effects of a microRNA binding site polymorphism in SLC19A1 on methotrexate concentrations in Chinese children with acute lymphoblastic leukemia.

Authors:  Shu-mei Wang; Lu-lu Sun; Wei-xin Zeng; Wan-shui Wu; Guo-liang Zhang
Journal:  Med Oncol       Date:  2014-06-14       Impact factor: 3.064

4.  Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.

Authors:  Niveditha Muralidharan; Christina Mary Mariaselvam; C B Mithun; Vir Singh Negi
Journal:  Clin Rheumatol       Date:  2015-03-15       Impact factor: 2.980

5.  Methotrexate recognition by the human reduced folate carrier SLC19A1.

Authors:  Nicholas J Wright; Justin G Fedor; Han Zhang; Pyeonghwa Jeong; Yang Suo; Jiho Yoo; Jiyong Hong; Wonpil Im; Seok-Yong Lee
Journal:  Nature       Date:  2022-09-07       Impact factor: 69.504

6.  Effect of genetic polymorphisms involved in folate metabolism on the concentration of serum folate and plasma total homocysteine (p-tHcy) in healthy subjects after short-term folic acid supplementation: a randomized, double blind, crossover study.

Authors:  Rona Cabo; Sigrunn Hernes; Audun Slettan; Margaretha Haugen; Shu Ye; Rune Blomhoff; M Azam Mansoor
Journal:  Genes Nutr       Date:  2015-03-11       Impact factor: 5.523

7.  Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population.

Authors:  Chunjuan He; Linna Peng; Shishi Xing; Dandan Li; Li Wang; Tianbo Jin
Journal:  Pharmgenomics Pers Med       Date:  2021-08-16

Review 8.  Emerging targets in cancer drug resistance.

Authors:  Shashank Kumar; Prem Prakash Kushwaha; Sanjay Gupta
Journal:  Cancer Drug Resist       Date:  2019-06-19

Review 9.  Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.

Authors:  Alfonso E Bello; Elizabeth L Perkins; Randy Jay; Petros Efthimiou
Journal:  Open Access Rheumatol       Date:  2017-03-31

10.  Discovery of Novel Biomarkers of Therapeutic Responses in Han Chinese Pemetrexed-Based Treated Advanced NSCLC Patients.

Authors:  Xiaoqing Zhang; Di Zhang; Lihua Huang; Guorong Li; Luan Chen; Jingsong Ma; Mo Li; Muyun Wei; Wei Zhou; Chenxi Zhou; Jinhang Zhu; Zhanhui Wang; Shengying Qin
Journal:  Front Pharmacol       Date:  2019-08-23       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.